Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 101 entries
Sorted by: Best Match Show Resources per page
Evaluation of Pharmaceutical Products of St. John's Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial.

Jundishapur journal of natural pharmaceutical products

Pakseresht S, Boustani H, Azemi ME, Nilsaz J, Babapour R, Haghdust MR.
PMID: 24624165
Jundishapur J Nat Pharm Prod. 2012;7(3):106-10. Epub 2012 Aug 25.

BACKGROUND: Major depressive disorder (MDD) is the most common disorder in our community. Hypericum perforatumm, is a herb with a long application history in treating depression. A controlled study to evaluate the effects of this herbal medicine in Iran...

Cite
Pakseresht S, Boustani H, Azemi ME, et al. Evaluation of Pharmaceutical Products of St. John's Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial. Jundishapur J Nat Pharm Prod. 2012;7(3):106-10
Pakseresht, S., Boustani, H., Azemi, M. E., Nilsaz, J., Babapour, R., & Haghdust, M. R. (2012). Evaluation of Pharmaceutical Products of St. John's Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial. Jundishapur journal of natural pharmaceutical products, 7(3), 106-10.
Pakseresht, Sirus, et al. "Evaluation of Pharmaceutical Products of St. John's Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial." Jundishapur journal of natural pharmaceutical products vol. 7,3 (2012): 106-10.
Pakseresht S, Boustani H, Azemi ME, Nilsaz J, Babapour R, Haghdust MR. Evaluation of Pharmaceutical Products of St. John's Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial. Jundishapur J Nat Pharm Prod. 2012;7(3):106-10. Epub 2012 Aug 25. PMID: 24624165; PMCID: PMC3941849.
Copy Download .nbib Format: NLM
Unusually high prolactin level for medication-induced hyperprolactinemia: a case report.

The Eurasian journal of medicine

Akbas EM, Gungor A, Ozdemir C, Bilen H.
PMID: 25610268
Eurasian J Med. 2013 Jun;45(2):138-40. doi: 10.5152/eajm.2013.28.

Hyperprolactinemia has a number of etiologies, including physiological, pathological and pharmacological causes. Hyperprolactinemia is frequently associated with the use of certain medications. Patients using medications known to cause hyperprolactinemia generally develop a mild form of the condition, and the...

Cite
Akbas EM, Gungor A, Ozdemir C, et al. Unusually high prolactin level for medication-induced hyperprolactinemia: a case report. Eurasian J Med. 2013;45(2):138-40doi: 10.5152/eajm.2013.28.
Akbas, E. M., Gungor, A., Ozdemir, C., & Bilen, H. (2013). Unusually high prolactin level for medication-induced hyperprolactinemia: a case report. The Eurasian journal of medicine, 45(2), 138-40. https://doi.org/10.5152/eajm.2013.28
Akbas, Emin M, et al. "Unusually high prolactin level for medication-induced hyperprolactinemia: a case report." The Eurasian journal of medicine vol. 45,2 (2013): 138-40. doi: https://doi.org/10.5152/eajm.2013.28
Akbas EM, Gungor A, Ozdemir C, Bilen H. Unusually high prolactin level for medication-induced hyperprolactinemia: a case report. Eurasian J Med. 2013 Jun;45(2):138-40. doi: 10.5152/eajm.2013.28. PMID: 25610268; PMCID: PMC4261487.
Copy Download .nbib Format: NLM
Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study.

Clinical epidemiology

Steffenak AK, Wilde-Larsson B, Nordström G, Skurtveit S, Hartz I.
PMID: 22936858
Clin Epidemiol. 2012;4:225-31. doi: 10.2147/CLEP.S31624. Epub 2012 Aug 20.

BACKGROUND: The purposes of this study were to investigate the prevalence of psychotropic (hypnotic, antidepressant, and anxiolytic) drug use among adolescents aged 15-16 years during the period 2006-2010 according to gender and subcategories of psychotropics, and to study psychotropic...

Cite
Steffenak AK, Wilde-Larsson B, Nordström G, et al. Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study. Clin Epidemiol. 2012;4:225-31doi: 10.2147/CLEP.S31624.
Steffenak, A. K., Wilde-Larsson, B., Nordström, G., Skurtveit, S., & Hartz, I. (2012). Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study. Clinical epidemiology, 4225-31. https://doi.org/10.2147/CLEP.S31624
Steffenak, Anne Kjersti Myhrene, et al. "Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study." Clinical epidemiology vol. 4 (2012): 225-31. doi: https://doi.org/10.2147/CLEP.S31624
Steffenak AK, Wilde-Larsson B, Nordström G, Skurtveit S, Hartz I. Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study. Clin Epidemiol. 2012;4:225-31. doi: 10.2147/CLEP.S31624. Epub 2012 Aug 20. PMID: 22936858; PMCID: PMC3429152.
Copy Download .nbib Format: NLM
Acute Liver Failure due to Trazodone and Diazepam.

GE Portuguese journal of gastroenterology

Carvalhana S, Oliveira A, Ferreira P, Resende M, Perdigoto R, Barroso E.
PMID: 28848778
GE Port J Gastroenterol. 2017 Jan;24(1):40-42. doi: 10.1159/000450878. Epub 2016 Nov 16.

Most antidepressant agents have the potential to cause liver injury, even at therapeutic doses. Nevertheless, drug-induced liver injury (DILI) from antidepressant agents is a rare event. There is no way to prevent idiopathic DILI, but the severity of the...

Cite
Carvalhana S, Oliveira A, Ferreira P, et al. Acute Liver Failure due to Trazodone and Diazepam. GE Port J Gastroenterol. 2016;24(1):40-42doi: 10.1159/000450878.
Carvalhana, S., Oliveira, A., Ferreira, P., Resende, M., Perdigoto, R., & Barroso, E. (2017). Acute Liver Failure due to Trazodone and Diazepam. GE Portuguese journal of gastroenterology, 24(1), 40-42. https://doi.org/10.1159/000450878
Carvalhana, Sofia, et al. "Acute Liver Failure due to Trazodone and Diazepam." GE Portuguese journal of gastroenterology vol. 24,1 (2017): 40-42. doi: https://doi.org/10.1159/000450878
Carvalhana S, Oliveira A, Ferreira P, Resende M, Perdigoto R, Barroso E. Acute Liver Failure due to Trazodone and Diazepam. GE Port J Gastroenterol. 2017 Jan;24(1):40-42. doi: 10.1159/000450878. Epub 2016 Nov 16. PMID: 28848778; PMCID: PMC5553376.
Copy Download .nbib Format: NLM
Risk factors for hospitalizations associated with depression among women during the years around a birth: a retrospective cohort study.

International journal of population data science

Fairthorne JC, Hanley GE, Brant R, Oberlander TF.
PMID: 34095525
Int J Popul Data Sci. 2019 Jan 21;4(1):453. doi: 10.23889/ijpds.v4i1.453.

INTRODUCTION: Socio-economic status (SES) is an important determinant of health. Low SES is associated with higher rates of prenatal and post-partum depression, and prenatal and post-partum depression are associated with sub-optimal maternal and infant health. Furthermore, increased negative effects...

Cite
Fairthorne JC, Hanley GE, Brant R, et al. Risk factors for hospitalizations associated with depression among women during the years around a birth: a retrospective cohort study. Int J Popul Data Sci. 2019;4(1):453doi: 10.23889/ijpds.v4i1.453.
Fairthorne, J. C., Hanley, G. E., Brant, R., & Oberlander, T. F. (2019). Risk factors for hospitalizations associated with depression among women during the years around a birth: a retrospective cohort study. International journal of population data science, 4(1), 453. https://doi.org/10.23889/ijpds.v4i1.453
Fairthorne, Jennifer Christine, et al. "Risk factors for hospitalizations associated with depression among women during the years around a birth: a retrospective cohort study." International journal of population data science vol. 4,1 (2019): 453. doi: https://doi.org/10.23889/ijpds.v4i1.453
Fairthorne JC, Hanley GE, Brant R, Oberlander TF. Risk factors for hospitalizations associated with depression among women during the years around a birth: a retrospective cohort study. Int J Popul Data Sci. 2019 Jan 21;4(1):453. doi: 10.23889/ijpds.v4i1.453. PMID: 34095525; PMCID: PMC8142953.
Copy Download .nbib Format: NLM
Anesthetic Considerations for Patients on Psychotropic Drug Therapies.

Neurology international

Harbell MW, Dumitrascu C, Bettini L, Yu S, Thiele CM, Koyyalamudi V.
PMID: 34940748
Neurol Int. 2021 Nov 29;13(4):640-658. doi: 10.3390/neurolint13040062.

Psychotropic drugs are used in the treatment of psychiatric and non-psychiatric conditions. Many patients who are on psychotropic medications may present for procedures requiring anesthesia. Psychotropic medications can have dangerous interactions with drugs commonly used in anesthesia, some of...

Cite
Harbell MW, Dumitrascu C, Bettini L, et al. Anesthetic Considerations for Patients on Psychotropic Drug Therapies. Neurol Int. 2021;13(4):640-658doi: 10.3390/neurolint13040062.
Harbell, M. W., Dumitrascu, C., Bettini, L., Yu, S., Thiele, C. M., & Koyyalamudi, V. (2021). Anesthetic Considerations for Patients on Psychotropic Drug Therapies. Neurology international, 13(4), 640-658. https://doi.org/10.3390/neurolint13040062
Harbell, Monica W, et al. "Anesthetic Considerations for Patients on Psychotropic Drug Therapies." Neurology international vol. 13,4 (2021): 640-658. doi: https://doi.org/10.3390/neurolint13040062
Harbell MW, Dumitrascu C, Bettini L, Yu S, Thiele CM, Koyyalamudi V. Anesthetic Considerations for Patients on Psychotropic Drug Therapies. Neurol Int. 2021 Nov 29;13(4):640-658. doi: 10.3390/neurolint13040062. PMID: 34940748.
Copy Download .nbib Format: NLM
Lipoic acid prevents mirtazapine-induced weight gain in mice without impairs its antidepressant-like action in a neuroendocrine model of depression.

Behavioural brain research

Oliveira TQ, Chaves Filho AJM, Jucá PM, Soares MVR, Cunha NL, Vieira CFX, Gadelha Filho CVJ, Viana GA, De Oliveira GMF, Macedo DS, Vasconcelos SMM.
PMID: 34798169
Behav Brain Res. 2022 Feb 15;419:113667. doi: 10.1016/j.bbr.2021.113667. Epub 2021 Nov 16.

Mirtazapine (MIRT) is a multi-target antidepressant used in treatment of severe depression with promising efficacy, but also with important side effects, mainly sedation and weight gain. Thus, the present study aimed to test the effects of the neuroprotective antioxidant...

Cite
Oliveira TQ, Chaves Filho AJM, Jucá PM, et al. Lipoic acid prevents mirtazapine-induced weight gain in mice without impairs its antidepressant-like action in a neuroendocrine model of depression. Behav Brain Res. 2021;419:113667doi: 10.1016/j.bbr.2021.113667.
Oliveira, T. Q., Chaves Filho, A. J. M., Jucá, P. M., Soares, M. V. R., Cunha, N. L., Vieira, C. F. X., Gadelha Filho, C. V. J., Viana, G. A., De Oliveira, G. M. F., Macedo, D. S., & Vasconcelos, S. M. M. (2022). Lipoic acid prevents mirtazapine-induced weight gain in mice without impairs its antidepressant-like action in a neuroendocrine model of depression. Behavioural brain research, 419113667. https://doi.org/10.1016/j.bbr.2021.113667
Oliveira, Tatiana de Queiroz, et al. "Lipoic acid prevents mirtazapine-induced weight gain in mice without impairs its antidepressant-like action in a neuroendocrine model of depression." Behavioural brain research vol. 419 (2022): 113667. doi: https://doi.org/10.1016/j.bbr.2021.113667
Oliveira TQ, Chaves Filho AJM, Jucá PM, Soares MVR, Cunha NL, Vieira CFX, Gadelha Filho CVJ, Viana GA, De Oliveira GMF, Macedo DS, Vasconcelos SMM. Lipoic acid prevents mirtazapine-induced weight gain in mice without impairs its antidepressant-like action in a neuroendocrine model of depression. Behav Brain Res. 2022 Feb 15;419:113667. doi: 10.1016/j.bbr.2021.113667. Epub 2021 Nov 16. PMID: 34798169.
Copy Download .nbib Format: NLM
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study.

Parkinsonism & related disorders

D'Alessandro R, Zenesini C, Baldin E, Bonavina G, Calandra-Buonaura G, Cortelli P, Fabbri G, Guarino M, Nassetti SA, Pantieri R, Samoggia G, Nonino F, Vignatelli L.
PMID: 34091375
Parkinsonism Relat Disord. 2021 Jun;87:137-141. doi: 10.1016/j.parkreldis.2021.04.023. Epub 2021 May 06.

BACKGROUND: Depression is more frequently associated with akinetic-rigid/postural instability gait difficulty subtypes of Parkinson's disease than with tremor-dominant subtype.OBJECTIVES: The aim of the study is to investigate the frequency of exposure to antidepressant drugs, as proxy of depression, before...

Cite
D'Alessandro R, Zenesini C, Baldin E, et al. Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study. Parkinsonism Relat Disord. 2021;87:137-141doi: 10.1016/j.parkreldis.2021.04.023.
D'Alessandro, R., Zenesini, C., Baldin, E., Bonavina, G., Calandra-Buonaura, G., Cortelli, P., Fabbri, G., Guarino, M., Nassetti, S. A., Pantieri, R., Samoggia, G., Nonino, F., Vignatelli, L. (2021). Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study. Parkinsonism & related disorders, 87137-141. https://doi.org/10.1016/j.parkreldis.2021.04.023
D'Alessandro, Roberto, et al. "Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study." Parkinsonism & related disorders vol. 87 (2021): 137-141. doi: https://doi.org/10.1016/j.parkreldis.2021.04.023
D'Alessandro R, Zenesini C, Baldin E, Bonavina G, Calandra-Buonaura G, Cortelli P, Fabbri G, Guarino M, Nassetti SA, Pantieri R, Samoggia G, Nonino F, Vignatelli L. Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study. Parkinsonism Relat Disord. 2021 Jun;87:137-141. doi: 10.1016/j.parkreldis.2021.04.023. Epub 2021 May 06. PMID: 34091375.
Copy Download .nbib Format: NLM
Desvenlafaxine-associated hyperglycemia: A case report and literature review.

The mental health clinician

Mekonnen AD, Mills AA, Wilhite AL, Hoffman TK.
PMID: 32420005
Ment Health Clin. 2020 May 07;10(3):85-89. doi: 10.9740/mhc.2020.05.085. eCollection 2020 May.

Desvenlafaxine is a potent selective serotonin and norepinephrine reuptake inhibitor used to treat depression and anxiety. Several antidepressants have been associated with drug-induced hyperglycemia, but currently there are no reports for desvenlafaxine. A case of suspected desvenlafaxine-induced hyperglycemia is...

Cite
Mekonnen AD, Mills AA, Wilhite AL, et al. Desvenlafaxine-associated hyperglycemia: A case report and literature review. Ment Health Clin. 2020;10(3):85-89doi: 10.9740/mhc.2020.05.085.
Mekonnen, A. D., Mills, A. A., Wilhite, A. L., & Hoffman, T. K. (2020). Desvenlafaxine-associated hyperglycemia: A case report and literature review. The mental health clinician, 10(3), 85-89. https://doi.org/10.9740/mhc.2020.05.085
Mekonnen, Andrea D, et al. "Desvenlafaxine-associated hyperglycemia: A case report and literature review." The mental health clinician vol. 10,3 (2020): 85-89. doi: https://doi.org/10.9740/mhc.2020.05.085
Mekonnen AD, Mills AA, Wilhite AL, Hoffman TK. Desvenlafaxine-associated hyperglycemia: A case report and literature review. Ment Health Clin. 2020 May 07;10(3):85-89. doi: 10.9740/mhc.2020.05.085. eCollection 2020 May. PMID: 32420005; PMCID: PMC7213951.
Copy Download .nbib Format: NLM
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F.
PMID: 34634679
Eur Neuropsychopharmacol. 2021 Oct 08;54:1-6. doi: 10.1016/j.euroneuro.2021.09.009. Epub 2021 Oct 08.

The spreading of the Severe Acute Respiratory Syndrome Coronavirus (COVID-19) pandemic could be associated with psychiatric implications. After COVID-19, depression was reported in 40% of patients at one-, three-, and six-months follow-up. Emerging literature suggests anti-inflammatory and antiviral properties...

Cite
Mazza MG, Zanardi R, Palladini M, et al. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2021;54:1-6doi: 10.1016/j.euroneuro.2021.09.009.
Mazza, M. G., Zanardi, R., Palladini, M., Rovere-Querini, P., & Benedetti, F. (2021). Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 541-6. https://doi.org/10.1016/j.euroneuro.2021.09.009
Mazza, Mario Gennaro, et al. "Rapid response to selective serotonin reuptake inhibitors in post-COVID depression." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 54 (2021): 1-6. doi: https://doi.org/10.1016/j.euroneuro.2021.09.009
Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2021 Oct 08;54:1-6. doi: 10.1016/j.euroneuro.2021.09.009. Epub 2021 Oct 08. PMID: 34634679; PMCID: PMC8500775.
Copy Download .nbib Format: NLM
How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Fabbri C, Serretti A.
PMID: 33124583
Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):484-492. doi: 10.9758/cpn.2020.18.4.484.

Depression is the single largest contributor to non-fatal health loss and affects 322 million people globally. The clinical heterogeneity of this disorder shows biological correlates and it makes the personalization of antidepressant prescription an important pillar of treatment. There...

Cite
Fabbri C, Serretti A. How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach. Clin Psychopharmacol Neurosci. 2020;18(4):484-492doi: 10.9758/cpn.2020.18.4.484.
Fabbri, C., & Serretti, A. (2020). How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 18(4), 484-492. https://doi.org/10.9758/cpn.2020.18.4.484
Fabbri, Chiara, and Serretti, Alessandro. "How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 18,4 (2020): 484-492. doi: https://doi.org/10.9758/cpn.2020.18.4.484
Fabbri C, Serretti A. How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach. Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):484-492. doi: 10.9758/cpn.2020.18.4.484. PMID: 33124583; PMCID: PMC7609216.
Copy Download .nbib Format: NLM
A case of venlafaxine-induced angioedema in an older adult.

SAGE open medical case reports

Griffin H, Pearson S, Linnebur S, Fixen D.
PMID: 34616557
SAGE Open Med Case Rep. 2021 Sep 30;9:2050313X211050465. doi: 10.1177/2050313X211050465. eCollection 2021.

Angioedema is a serious adverse event that can manifest as lower extremity edema, face swelling, rash, hives, and a swollen tongue, which can sometimes lead to airway constriction and death. It is a well-documented reaction within the angiotensin-converting enzyme...

Cite
Griffin H, Pearson S, Linnebur S, et al. A case of venlafaxine-induced angioedema in an older adult. SAGE Open Med Case Rep. 2021;9:2050313X211050465doi: 10.1177/2050313X211050465.
Griffin, H., Pearson, S., Linnebur, S., & Fixen, D. (2021). A case of venlafaxine-induced angioedema in an older adult. SAGE open medical case reports, 92050313X211050465. https://doi.org/10.1177/2050313X211050465
Griffin, Hailee, et al. "A case of venlafaxine-induced angioedema in an older adult." SAGE open medical case reports vol. 9 (2021): 2050313X211050465. doi: https://doi.org/10.1177/2050313X211050465
Griffin H, Pearson S, Linnebur S, Fixen D. A case of venlafaxine-induced angioedema in an older adult. SAGE Open Med Case Rep. 2021 Sep 30;9:2050313X211050465. doi: 10.1177/2050313X211050465. eCollection 2021. PMID: 34616557; PMCID: PMC8488410.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 101 entries